These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6538093)

  • 1. Diurnal variation of uterine contractility.
    Lundström V; Eneroth P; Swahn ML
    Br J Obstet Gynaecol; 1984 Feb; 91(2):155-9. PubMed ID: 6538093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin and prostaglandins in premenstrual pain and primary dysmenorrhea.
    Strömberg P; Akerlund M; Forsling ML; Granström E; Kindahl H
    Acta Obstet Gynecol Scand; 1984; 63(6):533-8. PubMed ID: 6542295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentrations of vasopressin and a prostaglandin F2 alpha metabolite in women with primary dysmenorrhoea before and during treatment with a combined oral contraceptive.
    Hauksson A; Akerlund M; Forsling ML; Kindahl H
    J Endocrinol; 1987 Nov; 115(2):355-61. PubMed ID: 3125302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution to the pathogenesis of dysmenorrhea.
    Zahradnik HP; Breckwoldt M
    Arch Gynecol; 1984; 236(2):99-108. PubMed ID: 6596911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous prostaglandins in dysmenorrhea and the effect of prostaglandin synthetase inhibitors (PGSI) on uterine contractility.
    Lundström V; Gréen K; Svanborg K
    Acta Obstet Gynecol Scand Suppl; 1979; 87():51-6. PubMed ID: 111466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is prostaglandin F2 alpha involved in the increased myometrial contractility of primary dysmenorrhoea?
    Lumsden MA; Kelly RW; Baird DT
    Prostaglandins; 1983 May; 25(5):683-92. PubMed ID: 6577521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandins, indomethacin and dysmenorrhea.
    Lundström V; Gréen K; Wiqvist N
    Prostaglandins; 1976 May; 11(5):893-907. PubMed ID: 935518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the prostaglandins on the uterus. Prostaglandins and uterine contractility.
    Bygdeman M; Bremme K; Gillespie A; Lundström V
    Acta Obstet Gynecol Scand Suppl; 1979; 87():33-8. PubMed ID: 288294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of primary prostaglandin (Pgs) and main metabolite of PgF2 alpha in blood plasma for diagnosis of primary dysmenorrhoea].
    Seifert B; Liedtke MP
    Zentralbl Gynakol; 1982; 104(10):577-83. PubMed ID: 6957086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menstrual-PGF2 alpha, PGE2 and TXA2 in normal and dysmenorrheic women and their temporal relationship to dysmenorrhea.
    Powell AM; Chan WY; Alvin P; Litt IF
    Prostaglandins; 1985 Feb; 29(2):273-90. PubMed ID: 3856904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandins in menstrual fluid in menorrhagia and dysmenorrhoea.
    Rees MC; Anderson AB; Demers LM; Turnbull AC
    Br J Obstet Gynaecol; 1984 Jul; 91(7):673-80. PubMed ID: 6589016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prostaglandins and dysmenorrhea effect of naproxen on prostaglandin concentrations in menstrual blood (author's transl)].
    Ninagawa T; Matsukawa R; Yoshio T; Kan S; Ito K
    Acta Obstet Gynaecol Jpn; 1981 Apr; 33(4):449-54. PubMed ID: 7234342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a vasopressin antagonist in women with dysmenorrhea.
    Valentin L; Sladkevicius P; Kindahl H; Broeders A; Marsal K; Melin P
    Gynecol Obstet Invest; 2000; 50(3):170-7. PubMed ID: 11014949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human salivary eicosanoids: circadian variation.
    Rigas B; Levine L
    Biochem Biophys Res Commun; 1983 Aug; 115(1):201-5. PubMed ID: 6351860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical studies of plasma PGF2 alpha M, the circulating prostaglandin F2 alpha metabolite.
    Walker V
    Clin Chim Acta; 1982 Sep; 124(3):327-37. PubMed ID: 7127845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of prostaglandins in vasopressin stimulation of the human uterus.
    Strömberg P; Akerlund M; Forsling ML; Kindahl H
    Br J Obstet Gynaecol; 1983 Apr; 90(4):332-7. PubMed ID: 6573182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High nocturnal body temperatures and disturbed sleep in women with primary dysmenorrhea.
    Baker FC; Driver HS; Rogers GG; Paiker J; Mitchell D
    Am J Physiol; 1999 Dec; 277(6):E1013-21. PubMed ID: 10600789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The myometrial response to intra-uterine administration of PGF2alpha and PGE2 in dysmenorrheic women.
    Lundström V
    Acta Obstet Gynecol Scand; 1977; 56(3):167-72. PubMed ID: 878858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproductive hormones in plasma over the menstrual cycle in primary dysmenorrhea compared with healthy subjects.
    Liedman R; Hansson SR; Howe D; Igidbashian S; McLeod A; Russell RJ; Akerlund M
    Gynecol Endocrinol; 2008 Sep; 24(9):508-13. PubMed ID: 18958771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen, progesterone, prolactin, prostaglandin E2, prostaglandin F2 alpha, 13,14-dihydro-15-keto-prostaglandin F2 alpha, and 6-keto-prostaglandin F1 alpha gradients across the uterus in women in labor and not in labor.
    Davidson BJ; Murray RD; Challis JR; Valenzuela GJ
    Am J Obstet Gynecol; 1987 Jul; 157(1):54-8. PubMed ID: 3474902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.